The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application (NDA) for Stapokibart to treat seasonal allergic rhinitis. The approval is ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

AIM ImmunoTech (AIM) announced its initiation of a plan to advance Ampligen as a vaccine adjuvant for avian influenza as part of the Company’s ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

A wild goose found in Putnam County tested positive for a “case of highly pathogenic avian influenza,” known as H5N1 or bird flu, but risk to the public remains low, the county’s health ...

A subtype of bird flu caused by avian influenza A (H5) virus has been spreading worldwide in wild birds with a few outbreaks in poultry, dairy cows and other mammals across the United States ...

The post-holiday influenza spike across New Jersey shows no signs of slowing down, as the Centers for Disease Control and Prevention reports a "very high" number of reported influenza cases.

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...